BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23186976)

  • 1. Incidental thyroid cancer in toxic and nontoxic goiter: Is TSH associated with malignanCy rate? Results of a meta-analysis.
    Negro R; Valcavi R; Toulis KA
    Endocr Pract; 2013; 19(2):212-8. PubMed ID: 23186976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?
    Lin YS; Wu HY; Yu MC; Hsu CC; Chao TC
    Medicine (Baltimore); 2016 Jul; 95(28):e4194. PubMed ID: 27428220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?
    Kaliszewski K; Strutyńska-Karpińska M; Zubkiewicz-Kucharska A; Wojtczak B; Domosławski P; Balcerzak W; Łukieńczuk T; Forkasiewicz Z
    PLoS One; 2016; 11(12):e0168654. PubMed ID: 28005977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of unsuspected thyroid cancer in multinodular thyroid disease.
    Karalus M; Tamatea JA; Conaglen HM; Meyer-Rochow GY; Conaglen JV; Elston MS
    N Z Med J; 2018 Jan; 131(1468):69-74. PubMed ID: 29346358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Rates of Underlying Thyroid Cancer in Patients Undergoing Thyroidectomy for Hyperthyroidism.
    Alvarez AL; Mulder M; Handelsman RS; Lew JI; Farra JC
    J Surg Res; 2020 Jan; 245():523-528. PubMed ID: 31450040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental carcinoma in multinodular goiter: risk factors.
    Botrugno I; Lovisetto F; Cobianchi L; Zonta S; Klersy C; Vailati A; Dionigi P; Jemos V
    Am Surg; 2011 Nov; 77(11):1553-8. PubMed ID: 22196673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
    Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
    Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of multinodular goiter.
    Hurley DL; Gharib H
    Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis.
    Gandolfi PP; Frisina A; Raffa M; Renda F; Rocchetti O; Ruggeri C; Tombolini A
    Acta Biomed; 2004 Aug; 75(2):114-7. PubMed ID: 15481700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
    Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
    Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?
    Tam AA; Ozdemir D; Alkan A; Yazicioglu O; Yildirim N; Kilicyazgan A; Ersoy R; Cakir B
    Surgery; 2019 Sep; 166(3):356-361. PubMed ID: 31104806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of thyroid carcinoma in multinodular goiter: prospective study.
    Pradhan GB; Shrestha R; Shrestha S; Neupane J; Bhattachan CL
    Nepal Med Coll J; 2011 Sep; 13(3):169-71. PubMed ID: 22808807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis.
    Gul K; Di Ri Koc A; Ki Yak G; Ersoy PE; Ugras NS; Ozdemi D; Ersoy R; Cakir B
    Minerva Endocrinol; 2009 Dec; 34(4):281-8. PubMed ID: 20046157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxicosis does not protect against incidental papillary thyroid cancer.
    Preece J; Grodski S; Yeung M; Bailey M; Serpell J
    Surgery; 2014 Nov; 156(5):1153-6. PubMed ID: 25151553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental cancer in multinodular goitre post thyroidectomy.
    Bombil I; Bentley A; Kruger D; Luvhengo TE
    S Afr J Surg; 2014 Feb; 52(1):5-9. PubMed ID: 24881131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
    PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer in patients with toxic nodular goiter--is the incidence increasing?
    Choong KC; McHenry CR
    Am J Surg; 2015 Jun; 209(6):974-6. PubMed ID: 25896315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors Associated with Thyroid Carcinoma in North Pakistan.
    Khan MA; Khan KH; Shah SA; Mir KA; Khattak M; Shahzad MF
    Asian Pac J Cancer Prev; 2016; 17(1):377-80. PubMed ID: 26838242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.